MRI-guided Transurethral Ultrasound Ablation (TULSA) for Prostate Cancer

Buy Lab Tests Online

madman

Super Moderator

In this 19-minute presentation, Laurence Klotz, MD, Professor of Surgery at the University of Toronto and the Sunnybrook Chair of Prostate Cancer Research, discusses the technology, procedure, outcomes, and regulatory environment surrounding MRI-guided transurethral ultrasound ablation (TULSA) treatment for patients with prostate cancer. He cites data from a clinical trial that demonstrates 96 percent of patients had a PSA reduction ≥75 percent at 12 months and at the 12-month MRI the median prostate volume had decreased from 41 to 4 cc (a decrease of 90 percent). Further, the treatment preserved continence and erectile function.

Screenshot (14625).png

Screenshot (14626).png

Screenshot (14629).png
Screenshot (14630).png

Screenshot (14632).png
 
Defy Medical TRT clinic doctor

madman

Super Moderator
*He cites data from a clinical trial that demonstrates 96 percent of patients had a PSA reduction ≥75 percent at 12 months and at the 12-month MRI the median prostate volume had decreased from 41 to 4 cc (a decrease of 90 percent). Further, the treatment preserved continence and erectile function
 
Buy Lab Tests Online

Sponsors

bodybuilder test discounted labs
Defy Medical Telemedicine hormones
Discounted lab tests
TRT in UK Balance my hormones
Testosterone books nelson vergel
Free Testosterone Book
Register on ExcelMale.com
Trimix HCG Offer Excelmale
Thumos USA men's mentoring and coaching
Testosterone TRT HRT Doctor Near Me

Online statistics

Members online
7
Guests online
6
Total visitors
13

Latest posts

Top